Efficacy of Quetiapine for Pediatric Delirium

Trial Profile

Efficacy of Quetiapine for Pediatric Delirium

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 30 Dec 2016

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Delirium
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Dec 2016 Status changed from active, no longer recruiting to discontinued.
    • 31 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 08 Dec 2015 Planned end date changed from 1 Dec 2016 to 1 Dec 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top